Tela Bio Inc Reports Results For The Quarter Ended September 30: Earnings Summary

TELA Bio

09/11/2024 12:28

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -45 cents.  The mean expectation of five analysts for the
quarter was for a loss of 40 cents per share. Wall Street
expected results to range from -44 cents to -31 cents per share.
    * Revenue rose 25.9% to $18.96 million from a year ago;
analysts
expected $18.85 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 42
cents​.
    * The company reported a quarterly loss of $10.37 million.
    * TELA Bio Inc shares had risen by 18.2% this quarter and
lost 54.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for TELA Bio Inc is
$9.00 
This summary was machine generated from LSEG data November 9 at
12:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.40          -0.42          Missed
 Jun. 30 2024      -0.47          -0.51          Missed
 Mar. 31 2024      -0.50          -0.23          Beat
 Dec. 31 2023      -0.43          -0.53          Missed